You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,101,576

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 7,101,576 protect, and when does it expire?

Patent 7,101,576 protects MEGACE ES and is included in one NDA.

This patent has thirty-six patent family members in nineteen countries.

Summary for Patent: 7,101,576

Patent landscape, scope, and claims:

Title:	Nanoparticulate megestrol formulations
Abstract:	The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
Inventor(s):	Hovey; Douglas (Trooper, PA), Pruitt; John (Collegeville, PA), Ryde; Tuula (Malvern, PA)
Assignee:	Elan Pharma International Limited (Dublin, IE)
Application Number:	10/412,669
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,101,576
Patent Claim Types: see list of patent claims	Use; Formulation; Composition;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 7,101,576

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Endo Operations	MEGACE ES	megestrol acetate	SUSPENSION;ORAL	021778-001	Jul 5, 2005	AB	RX	Yes	Yes	7,101,576	⤷ Subscribe				TREATMENT OF ANOREXIA, CACHEXIA, OR AN UNEXPLAINED, SIGNIFICANT WEIGHT LOSS IN PATIENTS WITH A DIAGNOSIS OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 7,101,576

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	539737	⤷ Subscribe
Australia	2003230885	⤷ Subscribe
Australia	2003231071	⤷ Subscribe
Australia	2006262144	⤷ Subscribe
Brazil	PI0612665	⤷ Subscribe
Canada	2481390	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.